Wayfinding Financial LLC bought a new stake in shares of MetLife, Inc. (NYSE:MET – Free Report) in the 4th quarter, HoldingsChannel.com reports. The institutional investor bought 3,460 shares of the financial services provider’s stock, valued at approximately $283,000.
Other hedge funds have also recently added to or reduced their stakes in the company. Retirement Wealth Solutions LLC bought a new stake in MetLife during the 4th quarter valued at approximately $32,000. Sierra Ocean LLC bought a new stake in MetLife during the 4th quarter valued at approximately $32,000. Values First Advisors Inc. bought a new stake in MetLife during the 4th quarter valued at approximately $36,000. Golden State Wealth Management LLC bought a new stake in MetLife during the 4th quarter valued at approximately $44,000. Finally, Atala Financial Inc bought a new stake in MetLife during the 4th quarter valued at approximately $45,000. Institutional investors own 94.99% of the company’s stock.
MetLife Stock Down 0.4 %
Shares of MET opened at $82.68 on Friday. The firm has a market capitalization of $56.33 billion, a price-to-earnings ratio of 13.85, a PEG ratio of 0.65 and a beta of 1.04. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.16 and a current ratio of 0.16. The business’s fifty day moving average price is $83.44 and its two-hundred day moving average price is $82.57. MetLife, Inc. has a 52 week low of $67.30 and a 52 week high of $89.05.
MetLife Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, March 11th. Stockholders of record on Tuesday, February 4th were given a $0.545 dividend. The ex-dividend date of this dividend was Tuesday, February 4th. This represents a $2.18 annualized dividend and a dividend yield of 2.64%. MetLife’s dividend payout ratio is currently 36.52%.
Wall Street Analysts Forecast Growth
A number of analysts have commented on the company. Cowen reiterated a “buy” rating on shares of MetLife in a research report on Friday, March 7th. JPMorgan Chase & Co. increased their target price on MetLife from $86.00 to $88.00 and gave the stock an “overweight” rating in a report on Tuesday, January 7th. StockNews.com cut MetLife from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. Keefe, Bruyette & Woods dropped their target price on MetLife from $100.00 to $98.00 and set an “outperform” rating for the company in a report on Wednesday, February 12th. Finally, Barclays dropped their target price on MetLife from $96.00 to $95.00 and set an “overweight” rating for the company in a report on Friday, February 7th. Two investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $94.58.
Get Our Latest Stock Analysis on MetLife
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Further Reading
- Five stocks we like better than MetLife
- What is a buyback in stocks? A comprehensive guide for investors
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- What Are Treasury Bonds?
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.